NHS will not fund new drug to slow Alzheimer’s
A new drug that slows the pace of Alzheimer's disease is too expensive for too little benefit to be used on the NHS in England, the drugs spending watchdog says. Donanemab was hailed as a turning point in the disease last year. But the National Institute ...
New Alzheimer’s drugs should be available on NHS, says patient’s wife
A wife whose husband will not be eligible for new Alzheimer’s drugs has implored health leaders to ensure that others like him will be able to access treatments. New disease-modifying Alzheimer’s drugs work best when they are given to patients in the early stages of disease.
The NHS is one of the largest studies of women’s risk factors for major chronic diseases. Initially designed to study the ...
The NHS has a backlog crisis a staff vacancy crisis and a mental health crisis. Public satisfaction is at an all-time low, ...
NHS care can be a “death sentence” for some patients, the Health Secretary has said as the Prime Minister called for better ...
The British public did not fail to disappoint after the government launched a public consultation to shape up the NHS.
Every NHS patient will carry their medical records with them in a ‘patient passport’ in the NHS app under new plans unveiled ...
Wes Streeting has appeared to confirm that Rachel Reeves will carry out a tax raid on national insurance contributions to ...
Radcliffe Place is the UK's only residential assessment unit which supports young people aged 16 to 25 with learning ...
15hon MSN
NHS patients are more willing to miss hospital appointments than the hairdresser or personal training sessions, a new survey ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback